These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activation of SIRT3 by Tanshinone IIA ameliorates renal fibrosis by suppressing the TGF-β/TSP-1 pathway and attenuating oxidative stress. Fan Y, Kang S, Shao T, Xu L, Chen J. Cell Signal; 2024 Oct; 122():111348. PubMed ID: 39153586 [Abstract] [Full Text] [Related]
3. The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation. Feng F, Cheng P, Zhang H, Li N, Qi Y, Wang H, Wang Y, Wang W. Drug Des Devel Ther; 2019 Oct; 13():4275-4290. PubMed ID: 31908414 [Abstract] [Full Text] [Related]
9. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy. Tian N, Gao Y, Wang X, Wu X, Zou D, Zhu Z, Han Z, Wang T, Shi Y. Drug Des Devel Ther; 2018 Oct; 12():2195-2211. PubMed ID: 30034224 [Abstract] [Full Text] [Related]
20. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis. Jiang Y, Hu F, Li Q, Shen C, Yang J, Li M. Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290 [Abstract] [Full Text] [Related] Page: [Next] [New Search]